Profusa Secures ISO 13485:2016 Certification for Lumee Oxygen Platform
Event summary
- Profusa received ISO 13485:2016 certification from GMED on October 15, 2026, covering its Lumee Oxygen Platform.
- The certification supports ongoing MDR conformity assessment activities for CE marking and EU commercialization.
- ISO 13485:2016 certification aligns with FDA's Quality Management System Regulation (QMSR) effective February 2, 2026.
- Profusa can now begin manufacturing the Lumee Oxygen Sensor Platform with the ISO certificate in hand.
The big picture
Profusa's ISO 13485:2016 certification is a critical step toward MDR certification and CE marking, enabling EU market entry. The certification also positions the company favorably under the FDA's updated QMSR framework, aligning its quality management system with international standards. This milestone underscores the growing importance of standardized quality systems in medical device commercialization, particularly in highly regulated markets like Europe and the U.S.
What we're watching
- Regulatory Timing
- Whether Profusa can complete remaining MDR conformity assessment activities and secure CE marking to enter the European market.
- Manufacturing Scale
- The pace at which Profusa can ramp up production of the Lumee Oxygen Platform following ISO certification.
- Cross-Border Alignment
- How ISO 13485:2016 certification may facilitate future FDA regulatory processes under the QMSR framework.
Related topics
